Provided by Tiger Trade Technology Pte. Ltd.

Merck

147.76
-0.5900-0.40%
Post-market: 148.470.7090+0.48%19:58 EDT
Volume:11.13M
Turnover:1.64B
Market Cap:364.55B
PE:116.09
High:148.69
Open:147.00
Low:145.95
Close:148.35
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.03
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.25%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.69
PE(LYR):20.30

Loading ...

Merck KGaA (0O14) Receives a Hold from Jefferies

TIPRANKS
·
Jul 28

Barclays Adjusts Merck & Co. Price Target to $150 From $140, Maintains Overweight Rating

MT Newswires Live
·
Jul 28

Merck & Co Inc : Bernstein Raises Target Price to $105 from $100

THOMSON REUTERS
·
Jul 27

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative

Simply Wall St.
·
Jul 26

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?

Simply Wall St.
·
Jul 25

Merck Launches Early Access Initiative for Monthly Oral HIV Prevention Drug Alimatravir

Deep News
·
Jul 24

Aspen Pharmacare: Under Agreement, Co to Receive Technical Package from Msd, Together with Licensing Rights Covering 129 Countries

THOMSON REUTERS
·
Jul 24

Merck Outlines Access Plan for Investigational Monthly HIV Prevention Pill

MT Newswires Live
·
Jul 24

Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer

MT Newswires Live
·
Jul 24

Merck announces initial access plans for alimatravir

TIPRANKS
·
Jul 24

Merck & Co - Signs Seven Voluntary Licensing Agreements with Generic Manufacturers in Africa and India

THOMSON REUTERS
·
Jul 24

Merck & Co - Royalty-free Agreements Enable Supply of Generic Alimatravir in 129 Lmics

THOMSON REUTERS
·
Jul 24

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Reuters
·
Jul 24

Merck: Voluntary Licensing Agreements for Alimatravir Cover 129 Countries

THOMSON REUTERS
·
Jul 24

Merck: Plans Initial Alimatravir Supply Pending Regulatory Approval, Generic Manufacturing Ramp-up in Licensed Territories

THOMSON REUTERS
·
Jul 24

Merck: Announces Initial Access Plans for Alimatravir in Low- and Middle Income Countries for Prevention of Hiv-1

THOMSON REUTERS
·
Jul 24

Merck: in Active Discussions with Fiocruz on Alimatravir Availability in Latin America & Brazil

THOMSON REUTERS
·
Jul 24

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

TIPRANKS
·
Jul 24

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers

MT Newswires Live
·
Jul 23